Important Safety Information on Strattera (atomoxetine hydrochloride) and the potential for behavioral and emotional changes, including risk of self-harm
September 30, 2005 03:44

Eli Lilly Canada Inc., following discussions with Health Canada is advising Canadians that Strattera (atomoxetine hydrochloride) will now carry a new warning. This new warning indicates that patients of all ages taking Strattera may experience behavioural and/or emotional changes that put them at increased risk of self harm.